Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/27/2011 | US20110263047 Peptide tag and uses thereof |
10/27/2011 | US20110263028 Meganuclease recombination system |
10/27/2011 | US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
10/27/2011 | US20110263026 Construction of Protein-Responsive shRNA/RNAi Control System Using RNP Motif |
10/27/2011 | US20110263025 Biodegradable polydisulfide amines for gene delivery |
10/27/2011 | US20110263024 Process of clean cloning |
10/27/2011 | US20110263023 Genes for modulating coffee maturation and methods for their use |
10/27/2011 | US20110263012 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
10/27/2011 | US20110263003 Microbacterial Peptide Deformylase |
10/27/2011 | US20110263001 Compositions and Methods for Engineering Cells |
10/27/2011 | US20110262999 Compositions and Methods Comprising Protease Variants |
10/27/2011 | US20110262998 Process for preparing inclusion body-forming protein |
10/27/2011 | US20110262978 Expression vector for pseudonocardia autotrophica |
10/27/2011 | US20110262977 Process for production of optically active amine derivative |
10/27/2011 | US20110262976 PRODUCTION OF R-a-LIPOIC ACID BY FERMENTATION USING GENETICALLY ENGINEERED MICROORGANISMS |
10/27/2011 | US20110262974 Novel enzymes for use in enzymatic bleaching of food products |
10/27/2011 | US20110262973 Methods and Compositions for DNA Manipulation |
10/27/2011 | US20110262972 Chondroitin Synthase, Method for Producing the Same and Method for Producing Saccharide Chain-Extended Chondroitin |
10/27/2011 | US20110262968 Antibodies that bind to psca proteins for diagnosis of cancer |
10/27/2011 | US20110262966 Dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants |
10/27/2011 | US20110262954 Shuttle vector based transformation system for pyrococcus furiosus |
10/27/2011 | US20110262953 Phosphate Limited Inducible Promoter and A Bacillus Expression System |
10/27/2011 | US20110262944 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus |
10/27/2011 | US20110262914 Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases |
10/27/2011 | US20110262913 Marking |
10/27/2011 | US20110262910 Marker for colon cancer and method for detecting colon cancer |
10/27/2011 | US20110262905 Kit for the optimisation of protein synthesis/secretion |
10/27/2011 | US20110262902 Cis-acting diversification activator and method for selective diversification of nucleic acids |
10/27/2011 | US20110262619 Polypeptide having phytase activity and increased temperature resistance of the enzyme activity, and nucleotide sequence coding said polypeptide |
10/27/2011 | US20110262591 Lipases with high specificity towards short chain fatty acids and uses thereof |
10/27/2011 | US20110262527 Cationic lipids and methods of use |
10/27/2011 | US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses |
10/27/2011 | US20110262483 Methods for isolating enveloped virus-based vlps free of infectious agents |
10/27/2011 | US20110262480 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-GMP synthesis obtained by said method |
10/27/2011 | US20110262479 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
10/27/2011 | US20110262476 Mutant bacterial glycoproteins and uses thereof |
10/27/2011 | US20110262474 Chimeric HIV Antigens |
10/27/2011 | US20110262471 Rab6kifl/kif20a epitope peptide and vaccines containing the same |
10/27/2011 | US20110262469 Malaria vaccine based on fragments and combination of fragments of the cs protein of plasmodium vivax |
10/27/2011 | US20110262463 Syngr4 for target genes of cancer therapy and diagnosis |
10/27/2011 | US20110262454 Novel anti-cd38 antibodies for the treatment of cancer |
10/27/2011 | US20110262447 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses |
10/27/2011 | US20110262439 Bispecific single chain antibodies with specificity for high molecular weight target antigens |
10/27/2011 | US20110262438 Biological materials related to cxcr7 |
10/27/2011 | US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs |
10/27/2011 | US20110262429 Human timp-1 antibodies |
10/27/2011 | US20110262428 Treating cancer by modulating rna helicases |
10/27/2011 | US20110262408 Furin-knockdown and gm-csf-augmented (fang) cancer vaccine |
10/27/2011 | US20110262406 Compositions and methods for targeted inactivation of hiv cell surface receptors |
10/27/2011 | US20110262399 Porphobilinogen deaminase gene therapy |
10/27/2011 | US20110262394 Dna constructs eliciting immune response against flavivirus and effective adjuvants |
10/27/2011 | US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
10/27/2011 | US20110262353 Muteins of hngal and related proteins with affinity for a given target |
10/27/2011 | DE102010028008A1 Modifying substrate specificity of polyol oxidase, comprises providing the polyol oxidase comprising specified amino acid sequences and introducing specified amino acid substitutions in the polyol oxidase |
10/27/2011 | CA2833912A1 Aav-based treatment of cholesterol-related disorders |
10/27/2011 | CA2833908A1 Cns targeting aav vectors and methods of use thereof |
10/27/2011 | CA2833905A1 Multicistronic expression constructs |
10/27/2011 | CA2796758A1 Combinations including cry3aa and cry6aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
10/27/2011 | CA2796730A1 Combinations including cry34ab/35ab and cry3ba proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
10/27/2011 | CA2796727A1 Combinations including cry34ab/35ab and cry3aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
10/27/2011 | CA2796670A1 Gene switch compositions and methods of use |
10/27/2011 | CA2796607A1 Lysosomal storage disease enzyme |
10/27/2011 | CA2796284A1 Cell-based production of nonulosonates |
10/27/2011 | CA2795815A1 Novel structurally designed shrnas |
10/27/2011 | CA2795436A1 Method for preparing arna and method for analysis of gene expression |
10/27/2011 | CA2793559A1 Enhanced methods for gene regulation in plants |
10/27/2011 | CA2789071A1 Antibodies against human csf-1r and uses thereof |
10/26/2011 | EP2381586A1 Spread spectrum meter reading system utilizing low speed frequency hopping |
10/26/2011 | EP2381256A1 Mammalian sweet and amino acid heterodimeric taste receptors |
10/26/2011 | EP2380993A1 Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation |
10/26/2011 | EP2380988A2 Transgenic plants with enhanced agronomic traits |
10/26/2011 | EP2380987A2 Soybean event 3560.4.3.5 and compositions and methods for the identification and/or detection thereof |
10/26/2011 | EP2380986A1 Use of stomatin (STM1) polynucleotides for achieving a pathogen resistance in plants |
10/26/2011 | EP2380985A1 Cells expressing vitamin K epoxide reductase and use thereof |
10/26/2011 | EP2380984A2 Nucleic acid |
10/26/2011 | EP2380983A2 RAGE fusion proteins, formulations, and methods of use thereof |
10/26/2011 | EP2380982A1 Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
10/26/2011 | EP2380981A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
10/26/2011 | EP2380980A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
10/26/2011 | EP2380979A1 Protein substance having triple helix structure and manufacturing method therefor |
10/26/2011 | EP2380978A2 Gene group applicable to cancer prognostication |
10/26/2011 | EP2380977A2 Gene group applicable to cancer prognostication |
10/26/2011 | EP2380976A1 Human anti-human influenza virus antibody |
10/26/2011 | EP2380914A1 Fusion proteins of apoptin-protein transduction domain of carboxyl-terminal end of ec-sod |
10/26/2011 | EP2380913A1 Novel anti-IGF-IR antibodies and uses thereof |
10/26/2011 | EP2380912A1 Novel anti-IGF-IR antibodies and uses thereof |
10/26/2011 | EP2380909A1 PTK-7 protein involved in breast cancer |
10/26/2011 | EP2380906A2 Artificial antibody polypeptides |
10/26/2011 | EP2380900A1 Isolation and use of ryanodine receptors |
10/26/2011 | EP2380899A1 Isolation and use of ryanodine receptors |
10/26/2011 | EP2380897A1 RNAi modulation of ApoB and uses thereof |
10/26/2011 | EP2380602A1 Nucleic acids containing plastics in complexed form and method for producing same |
10/26/2011 | EP2380595A1 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
10/26/2011 | EP2380594A1 Use of serum albumin binding peptides conjugates for the preparation of a medicament |
10/26/2011 | EP2380435A2 Feline-derived protein and method for production thereof |
10/26/2011 | EP2379753A2 Single-cell nucleic acid analysis |
10/26/2011 | EP2379750A2 Selection of animals for desired milk and/or tissue profile |
10/26/2011 | EP2379748A2 Multibase delivery for long reads in sequencing by synthesis protocols |
10/26/2011 | EP2379739A1 Method of breeding cysdv-resistant cucumber plants |
10/26/2011 | EP2379730A1 Method for the preparation of diols |